X
Get new exclusive access to healthcare business reports & breaking news
Anca Spanu Anca's career in journalism spans over 2 decades. She has served as staff writer, editor and deputy chief editor at various media outlets all over the world. At Healthcare Weekly, Anca writes about current events, innovations in the healthcare space and events/ conferences with a focus on investing & startups.
Novartis announced July 17th that it has acquired DTx Pharma, a San-Diego based, preclinical stage biotechnology company focused ...
Novartis announced June 30th that it has signed an agreement to divest ‘front of eye’ ophthalmology assets to ...
Last week proved to be a challenging one for Sangamo Therapeutics. The gene-based therapy biotech company recently announced ...
New data on Zolgensma, a SMA gene therapy drug, has been released to showcase that the product is ...
Swiss software company RetinAL Medical AG announced on December 8, 2020, that they have signed a multi-year agreement ...
Swiss pharma giant, Novartis has completed the acquisition of Amblyotech, a U.S.-based startup that uses 3D and video ...
Pharmaceutical company Novartis has teamed up with Microsoft in a five-year artificial intelligence deal. The two companies plan ...
The U.S. Food and Drug Administration (FDA) has approved a therapy that costs $2.125 million per patient — ...
The healthcare system needs to become fully digital as soon as possible. Even though the start has been ...
